Inflammatory Marker Testing in Greenville, SC
Inflammatory Marker Testing at IHP Greenville. Dr. Hendry, DAOM — functional medicine, root-cause diagnostics, personalized care. Call (864) 365-6156.
"Dr. Hendry spent a long time going over my particular medical situation and explaining his recommendations for getting my immune system back on track. I received acupuncture and supplements to start my treatment."
— Cam Norden · July 2025 · Google Review
Houston's cardiovascular research established that hs-CRP, homocysteine, fibrinogen, and oxidized LDL independently predict cardiovascular events — and that approximately half of all heart attacks occur in patients with normal LDL. The inflammatory markers are what the standard lipid panel misses. I run inflammatory markers routinely because chronic low-grade inflammation is the common upstream driver of the conditions I see most: autoimmune disease, metabolic syndrome, neurodegenerative processes, chronic pain. Identifying elevated hs-CRP at 4.2 mg/L gives me a measurable target and a mechanism to treat. Retesting at 90 days confirms whether the intervention worked.
How Inflammatory Marker Testing Works
Inflammatory marker testing at IHP typically includes: high-sensitivity CRP (hsCRP — the most clinically validated cardiovascular inflammation marker), homocysteine (reflects methylation status and cardiovascular risk), ferritin (an acute phase reactant elevated in inflammation — often the first marker to show systemic inflammatory stress), fibrinogen, and IL-6 or TNF-alpha for specific inflammatory profiles. Results are interpreted in the context of your full clinical picture.
Conditions Treated with Inflammatory Marker Testing
Multi-Marker Inflammatory Risk Assessment vs. Standard Lipid Panel Alone
A 57-year-old male with no traditional cardiovascular risk factors, a total cholesterol of 185 mg/dL, and an LDL of 98 mg/dL is told by his cardiologist that his cardiovascular risk is low and no intervention is needed. Two years later, he sustains a non-ST-elevation myocardial infarction. This clinical scenario is not rare; it is the documented limitation of lipid-panel-centric risk assessment. Retrospective analysis of his bloodwork from that annual physical reveals that hs-CRP had been ordered once as a stand-alone add-on and measured 4.6 mg/L. Homocysteine was not tested; he carries a compound heterozygous MTHFR variant. Fibrinogen was not tested; it measured 412 mg/dL on post-event workup. Each of these values represents a modifiable risk factor with a specific nutritional or botanical intervention: methylated folate and B12 for homocysteine, omega-3 at therapeutic dose for hs-CRP, and magnesium plus nattokinase for fibrinogen. Our inflammatory panel does not replace cardiology evaluation. It identifies the correctable upstream drivers of arterial inflammation that predetermine event risk independently of cholesterol, providing an actionable prevention window that standard lipid monitoring does not offer.
Research & Evidence
Standard lipid panels measure total cholesterol, LDL, HDL, and triglycerides, a framework that identifies approximately 50% of patients who experience myocardial infarction, since the remaining half present with cholesterol values considered acceptable by conventional standards. The missing variable is arterial inflammation. Houston (World J Cardiol. 2014) reviewed evidence that hs-CRP, homocysteine, fibrinogen, and oxidized LDL are independent cardiovascular risk predictors that add significant prognostic information beyond the standard lipid panel. Specifically, homocysteine above 10 micromol/L independently damages endothelial cells through oxidative mechanisms, and its elevation is correctable with methylated B vitamins in patients with MTHFR variants that impair folate metabolism. Dantzer et al. (Nat Rev Neurosci. 2008) demonstrated that IL-6 produced in adipose tissue and the gut wall drives CRP synthesis in the liver, creating a measurable inflammatory cascade that originates in gut and metabolic dysfunction. Huang (Dis Model Mech. 2009) documented that oxidized LDL, not total LDL particle count, initiates the foam cell transformation in arterial walls that constitutes atherosclerotic plaque formation, making oxidized LDL a more mechanistically direct marker than LDL cholesterol. Our inflammatory panel includes hs-CRP, IL-6, homocysteine, fibrinogen, oxidized LDL, Lp(a), and ferritin, providing a multi-marker cardiovascular risk assessment grounded in arterial biology.
Your First Appointment
Bring any prior inflammatory lab results (CRP, ESR, etc.). Describe your inflammatory history — known diagnoses, joint involvement, skin manifestations, systemic symptoms.
Why Dr. Hendry for Inflammatory Marker Testing
Dr. Hendry's research publications — including work on cytokine-related symptom management — give him a scientist's understanding of inflammatory markers and their clinical significance.